2[2]Lardinois D,Weder W,Hany TF,et al.Staging of nonsmall-cell lung cancer with integrated positron-emission tomography and computed tomography[J].N Engl J Med,2003,348(25):2500-2507.
3[3]Cohade C,Osman MM,Leal J,et al.Direct comparison of FDG-PET and PET-CT imaging in staging and restaging patients with lung cancer[J].J Nucl Med,2003,44(11):1797-1803.
4Coleman RE. PET in lung cancer. J Nucl Med, 1999, 40: 814-820.
5Dominique D. Oncological application of FDG PET imaging. J Nucl Med,1999, 40: 1706-1715.
6Antoch G, Stattaus J, Nemat AT, et al. Non-small-cell lung cancer: dual-modality PET/CT in preoperative staging. Radiology, 2003, 229: 526-533.
7Lardinois D, Weder W, Hany TF, et al. Staging of non-small-cell lung cancer with integrated positron emission tomography and computed tomography. New Engl J Med, 2003, 348: 2500-2507.
8Ciemik IF, Dizendorf E, Baumert BG, et al. Radiation treatment planning with an integrated positron emission and computer tomography (PET/CT):a feasibility study. Int J Radiat Oncol Biol Phys, 2003, 57: 853-863.
9Lowe V J, Fletcher JW, Gobar L, et al. Prospective investigation of PET in lung nodules. J Clin Oncol, 1998, 16: 1075-1084.
10Kostakoglu L, Agress H Jr, Goldsmith SJ. Clinical role of FDG PET in evaluation of cancer patients. Radiographic s, 2003,23: 315-340.
5Chapman JD, Bradley JD, Eary JF, et al. Molecular ( functional) imaging for radiotherapy applications:an RTOG symposium[J]. Int J Radiat Oncol Biol Phys,2003 ,55 :294.
6Seltzer MA, Yap CS, Silveman DH, et al. The impact of PET on the management of lung cancer: the referring physician' perspective[J]. J Nucl Med,2002,43(6) :752.
7KalffV , Hicks RJ , Mad Manus MP , et al. Clinical impact of 18F-fluorodeoxyglucose positron emission tomography in patients with non-small cell lung cancer a prospective study [J]. J Clin Oncol,2001,19(1) :111.
8Mac Manus MP,Hicks RJ,Ball DL,et al. F-18 fluorodexyglucose positron emission tomography staging in radical radiotherapy candidates with non-small cell lung carcinoma powerful correlation with survival and high impact on treatment [J]. Cancer,2001,92(4) :886.
9Rasch C, Barillot I, Remeijer P, et al. Definition of the prostate in CT and MRI:a multi-observer study [ J]. Int J Radiat Biol Phys, 1998,43 ( 1 ) :57.
10Schmidt S, Nestle U,Walter,et al. Optimization of radiotherapy planing for non-small cell lung cancer (NSCLC) using 18 FDG-PET[ J]. Nucle Medizin,2002,41 (5) :217.
